INSULIN, BIOSIMILAR PRODUCTS - Pan Mersey APC Skip to main content Help with accessibility Skip to main navigation

INSULIN, BIOSIMILAR PRODUCTS

Last Updated: 24 February 2016

Body System: Endocrine System

Amber initiated

The Pan Mersey Area Prescribing Committee recommends the biosimilar insulin products for specific patient groups and taking into consideration the key safety implications.